↓ Skip to main content

Delta tocotrienol in recurrent ovarian cancer. A phase II trial

Overview of attention for article published in Pharmacological Research, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#39 of 3,504)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
13 news outlets
twitter
5 X users
video
1 YouTube creator

Readers on

mendeley
67 Mendeley